Vitamin D Deficiency in COVID-19 Patients and Role of Calcifediol Supplementation
Hypovitaminosis D has been associated with worse outcome in respiratory tract infections, with conflicting opinions regarding its role in Coronavirus-19 disease (COVID-19). Our study aimed to evaluate the possible relationship between 25-OH vitamin D (25OHD) values and the following conditions in pa...
Main Authors: | Christian Mingiano, Tommaso Picchioni, Guido Cavati, Filippo Pirrotta, Marco Calabrese, Ranuccio Nuti, Stefano Gonnelli, Alberto Fortini, Bruno Frediani, Luigi Gennari, Daniela Merlotti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/15/15/3392 |
Similar Items
-
Calcifediol: Why, When, How Much?
by: Simone Donati, et al.
Published: (2023-04-01) -
Calcifediol in the management of vitamin D deficiency-related skeletal and extraskeletal diseases: overview and clinical cases
by: Enrique Casado, et al.
Published: (2023-09-01) -
Cholecalciferol or Calcifediol in the Management of Vitamin D Deficiency
by: Manuel Sosa Henríquez, et al.
Published: (2020-05-01) -
Calcifediol (25OHD) Deficiency and Its Treatment in Women’s Health and Fertility
by: Ana Arnanz, et al.
Published: (2022-04-01) -
25(OH)Vitamin D Deficiency and Calcifediol Treatment in Pediatrics
by: Luis Castano, et al.
Published: (2022-04-01)